These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23986522)

  • 1. Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes.
    Mazagova M; Buikema H; van Buiten A; Duin M; Goris M; Sandovici M; Henning RH; Deelman LE
    Am J Physiol Renal Physiol; 2013 Nov; 305(9):F1249-64. PubMed ID: 23986522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
    Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
    Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
    Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V; Kulkarni O; Clauss S; Anders H-
    Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.
    Shiota A; Yamamoto K; Ohishi M; Tatara Y; Ohnishi M; Maekawa Y; Iwamoto Y; Takeda M; Rakugi H
    Hypertens Res; 2010 Apr; 33(4):298-307. PubMed ID: 20186149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
    Elmarakby AA; Faulkner J; Al-Shabrawey M; Wang MH; Maddipati KR; Imig JD
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1307-17. PubMed ID: 21832210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.
    Lassila M; Seah KK; Allen TJ; Thallas V; Thomas MC; Candido R; Burns WC; Forbes JM; Calkin AC; Cooper ME; Jandeleit-Dahm KA
    J Am Soc Nephrol; 2004 Aug; 15(8):2125-38. PubMed ID: 15284298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney.
    Falke LL; Dendooven A; Leeuwis JW; Nguyen TQ; van Geest RJ; van der Giezen DM; Broekhuizen R; Lyons K; Stoop R; Kemperman H; Schlingemann R; Joles JA; Goldschmeding R
    Matrix Biol; 2012; 31(7-8):421-31. PubMed ID: 23199377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP synthase subunit-β down-regulation aggravates diabetic nephropathy.
    Guan SS; Sheu ML; Wu CT; Chiang CK; Liu SH
    Sci Rep; 2015 Oct; 5():14561. PubMed ID: 26449648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
    Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB
    Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen VIII influences epithelial phenotypic changes in experimental diabetic nephropathy.
    Loeffler I; Liebisch M; Wolf G
    Am J Physiol Renal Physiol; 2012 Sep; 303(5):F733-45. PubMed ID: 22759394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
    Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium.
    Mazagova M; Buikema H; Landheer SW; Vavrinec P; Buiten Av; Henning RH; Deelman LE
    Am J Physiol Heart Circ Physiol; 2013 Mar; 304(5):H709-18. PubMed ID: 23262134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10.
    Sayyed SG; Gaikwad AB; Lichtnekert J; Kulkarni O; Eulberg D; Klussmann S; Tikoo K; Anders HJ
    Nephrol Dial Transplant; 2010 Jun; 25(6):1811-7. PubMed ID: 20067909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.
    Kamijo-Ikemori A; Sugaya T; Sekizuka A; Hirata K; Kimura K
    Nephrol Dial Transplant; 2009 Mar; 24(3):788-800. PubMed ID: 18854419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
    PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy.
    Tan Y; Keum JS; Wang B; McHenry MB; Lipsitz SR; Jaffa AA
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1026-35. PubMed ID: 17596525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.
    Falkevall A; Mehlem A; Palombo I; Heller Sahlgren B; Ebarasi L; He L; Ytterberg AJ; Olauson H; Axelsson J; Sundelin B; Patrakka J; Scotney P; Nash A; Eriksson U
    Cell Metab; 2017 Mar; 25(3):713-726. PubMed ID: 28190774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
    Lin Y; Sun Z
    J Endocrinol; 2011 May; 209(2):185-91. PubMed ID: 21307121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.